Does restaging transurethral resection of bladder tumor influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience | Zendy

AI Assistant Blog Pricing

Does restaging transurethral resection of bladder tumor influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.